Low apolipoprotein a1 is significantly associated with decreased risk of cardiovascular events in anticoagulated patients with atrial fibrillation: insights from the ARISTOTLE trial.
Event:
ESC Congress 2017
Topic:
Atrial fibrillation (AF)
Session:
Atrial fibrillation obesity
